Schroder Investment Management Group’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $107M | Buy |
198,974
+10,849
| +6% | +$6.09M | 0.08% | 202 |
|
|
2026
Q1 | $106M | Sell |
188,125
-146,662
| -44% | -$94M | 0.09% | 182 |
|
|
2025
Q4 | $226M | Buy |
334,787
+11,482
| +4% | +$7.82M | 0.17% | 105 |
|
|
2025
Q3 | $204M | Buy |
323,305
+7,520
| +2% | +$4.56M | 0.16% | 118 |
|
|
2025
Q2 | $169M | Buy |
315,785
+235,863
| +295% | +$113M | 0.14% | 130 |
|
|
2025
Q1 | $33.6M | Buy |
79,922
+6,798
| +9% | +$2.95M | 0.03% | 369 |
|
|
2024
Q4 | $30.2M | Sell |
73,124
-6,041
| -8% | -$2.65M | 0.03% | 417 |
|
|
2024
Q3 | $40.5M | Sell |
79,165
-125,187
| -61% | -$60.8M | 0.04% | 342 |
|
|
2024
Q2 | $99.6M | Buy |
204,352
+105,861
| +107% | +$53.1M | 0.11% | 164 |
|
|
2024
Q1 | $53.2M | Buy |
98,491
+9,336
| +10% | +$5.1M | 0.06% | 277 |
|
|
2023
Q4 | $49.5M | Buy |
89,155
+1,118
| +1% | +$525K | 0.06% | 275 |
|
|
2023
Q3 | $38.5M | Sell |
88,037
-1,576
| -2% | -$786K | 0.06% | 307 |
|
|
2023
Q2 | $45M | Buy |
89,613
+2,762
| +3% | +$1.32M | 0.06% | 302 |
|
|
2023
Q1 | $43.4M | Buy |
86,851
+27,341
| +46% | +$13.1M | 0.06% | 302 |
|
|
2022
Q4 | $24.3M | Sell |
59,510
-52,770
| -47% | -$20.5M | 0.04% | 411 |
|
|
2022
Q3 | $36.6M | Sell |
112,280
-16,225
| -13% | -$5.96M | 0.06% | 306 |
|
|
2022
Q2 | $45.1M | Buy |
128,505
+5,364
| +4% | +$2.19M | 0.07% | 273 |
|
|
2022
Q1 | $67.6M | Sell |
123,141
-37,236
| -23% | -$19.6M | 0.09% | 224 |
|
|
2021
Q4 | $106M | Buy |
160,377
+13,473
| +9% | +$8.46M | 0.14% | 158 |
|
|
2021
Q3 | $91.4M | Sell |
146,904
-27,949
| -16% | -$18.8M | 0.14% | 156 |
|
|
2021
Q2 | $110M | Buy |
174,853
+12,075
| +7% | +$6.67M | 0.14% | 142 |
|
|
2021
Q1 | $79.6M | Buy |
162,778
+43,027
| +36% | +$21.6M | 0.1% | 190 |
|
|
2020
Q4 | $59.9M | Buy |
119,751
+13,586
| +13% | +$6.08M | 0.08% | 238 |
|
|
2020
Q3 | $40.8M | Buy |
106,165
+23,598
| +29% | +$8.72M | 0.07% | 282 |
|
|
2020
Q2 | $27.3M | Buy |
82,567
+12,491
| +18% | +$3.62M | 0.05% | 350 |
|
|
2020
Q1 | $17.8M | Sell |
70,076
-25,750
| -27% | -$6.72M | 0.04% | 394 |
|
|
2019
Q4 | $25M | Buy |
95,826
+24,627
| +35% | +$6.49M | 0.04% | 439 |
|
|
2019
Q3 | $19.4M | Sell |
71,199
-94,297
| -57% | -$26.2M | 0.03% | 457 |
|
|
2019
Q2 | $45.6M | Sell |
165,496
-54,977
| -25% | -$13.5M | 0.03% | 428 |
|
|
2019
Q1 | $49.3M | Buy |
220,473
+17,110
| +8% | +$3.53M | 0.09% | 270 |
|
|
2018
Q4 | $37.8M | Buy |
203,363
+52,470
| +35% | +$10.8M | 0.07% | 293 |
|
|
2018
Q3 | $37.7M | Buy |
150,893
+40,617
| +37% | +$9.86M | 0.06% | 330 |
|
|
2018
Q2 | $24M | Buy |
110,276
+54,555
| +98% | +$11.2M | 0.04% | 422 |
|
|
2018
Q1 | $10.7M | Buy |
55,721
+5,913
| +12% | +$1.09M | 0.02% | 596 |
|
|
2017
Q4 | $7.79M | Sell |
49,808
-36,610
| -42% | -$5.76M | 0.01% | 699 |
|
|
2017
Q3 | $13.3M | Buy |
86,418
+19,562
| +29% | +$3.09M | 0.02% | 559 |
|
|
2017
Q2 | $10.7M | Buy |
66,856
+49,310
| +281% | +$8.01M | 0.02% | 587 |
|
|
2017
Q1 | $2.71M | Sell |
17,546
-28,854
| -62% | -$3.98M | ﹤0.01% | 802 |
|
|
2016
Q4 | $5.44M | Sell |
46,400
-22,313
| -32% | -$2.55M | 0.01% | 704 |
|
|
2016
Q3 | $7.75M | Buy |
68,713
+63,293
| +1,168% | +$6.67M | 0.01% | 672 |
|
|
2016
Q2 | $503K | Buy |
+5,420
| New | +$465K | ﹤0.01% | 968 |
|
|
2014
Q1 | – | Sell |
-55,400
| Closed | -$2.95M | – | 1463 |
|
|
2013
Q4 | $2.95M | Sell |
55,400
-23,200
| -30% | -$1.22M | ﹤0.01% | 881 |
|
|
2013
Q3 | $3.92M | Buy |
78,600
+21,000
| +36% | +$1.01M | 0.01% | 808 |
|
|
2013
Q2 | $2.58M | Buy |
+57,600
| New | +$2.52M | 0.01% | 854 |
|
Other funds holding IDXX
Schroder Investment Management Group's IDXX Position: Q2 2026 in Review
Schroder Investment Management Group increased its Idexx Laboratories (IDXX) stake by 5.8% in Q2 2026, buying an estimated $6.09M and bringing the position to 198,974 shares worth $107M. The position accounts for 0.08% of the portfolio, ranked #202.
Schroder Investment Management Group first reported a position in IDXX in Q2 2013 and has held it in 44 quarters since. The position peaked at $226M in Q4 2025. 1,300 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Schroder Investment Management Group held 198,974 shares of Idexx Laboratories worth $107M as of Q2 2026.
- Schroder Investment Management Group bought 10,849 Idexx Laboratories shares in Q2 2026, an estimated $6.09M.
- Idexx Laboratories made up 0.08% of Schroder Investment Management Group's portfolio in Q2 2026, its #202 holding.
- Schroder Investment Management Group first reported a position in Idexx Laboratories in Q2 2013 and has held it in 44 quarters since.
- Schroder Investment Management Group's Idexx Laboratories position peaked at $226M in Q4 2025.
- 1,300 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Schroder Investment Management Group's 13F filing for Q2 2026, filed 13 Aug 2026.